Task order title: preventing lung adenocarcinoma (luad) using trail inducing agent, ONC201 base contract title: prevent preclinical drug development program: preclinical efficacy and intermediate…
Active Awarded Last action
- Contract number
- 75N91022F00003
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $982,258
Award facts
- Opportunity
-
- TORFP2022E08 Solicitation number
- Contract value 100% obligated
- $982,258.00 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $982,258 |
About this award
The National Cancer Institute issued a delivery order to the University of Oklahoma on September 8, 2022, under the PREVENT Preclinical Drug Development Program IDIQ for preclinical efficacy studies and biomarker development of ONC201, a TRAIL-inducing agent, targeting lung adenocarcinoma prevention. The order carries a ceiling value of $982,258 and is firm fixed price with an ultimate completion date of August 7, 2027.
Place of performance is Oklahoma City, Oklahoma. The University of Oklahoma Health Sciences Center, the awardee's Health Sciences Center division, self-performed all reported work through FY2025 with no subcontractors. Government-paid hourly rates trended upward across the reported period: $317.16 per hour in FY2023, rising to $552.43 per hour in FY2024. Labor footprint in FY2025 was 0.8 FTEs. Invoiced amounts across the reporting window ran $324 thousand in FY2023, $243 thousand in FY2024, and $324 thousand in FY2025.
Description
Task order title: preventing lung adenocarcinoma (luad) using trail inducing agent, ONC201 base contract title: prevent preclinical drug development program: preclinical efficacy and intermediate biomarkers
Quick answers
Who was awarded contract 75N91022F00003?
75N91022F00003 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 8, 2022.
How much is contract 75N91022F00003 worth?
The government has obligated $982,258 on 75N91022F00003.
Is contract 75N91022F00003 an order under another contract?
Yes. 75N91022F00003 is a delivery order under 75N91019D00020, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91022F00003 competed?
The extent of competition for 75N91022F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award